Natalie Sacks - Nov 11, 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Chief Medical Officer
Signature
/s/ Natalie Sacks by Georgia Erbez, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Nov 11, 2021
Transactions value $
$0
Form type
4
Date filed
11/15/2021, 03:03 PM
Previous filing
Jul 22, 2021
Next filing
Dec 21, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +155K $0.00 155K Nov 11, 2021 Common Stock 155K $7.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023.